Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Sequencing Reagents market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Sequencing Reagents market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Sequencing Reagents market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Sequencing Reagents products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Sequencing Reagents products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Sequencing Reagents market.
To learn more about this report
Increasing research and development spending on Sequencing Reagents development has been the leading industry trend of Sequencing Reagents market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Sanger Sequencing, Next Generation Sequencing, Third Generation Sequencing, Other |
| By Application Outlook | Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Thermo Fisher Scientific, Bioline, Takara Bio, ArcherDX, Fluidigm Corporation, Pacific Biosciences of California, F. Hoffmann-La Roche AG, Oxford Nanopore Technologies, Agilent Technologies, Illumina, BGI, Qiagen |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Sequencing Reagents Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Sequencing Reagents Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Sequencing Reagents Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Sequencing Reagents Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Sanger Sequencing
4.2.2 Next Generation Sequencing
4.2.3 Third Generation Sequencing
4.2.4 Other
4.4 Type Comparison Matrix
4.5 Global Sequencing Reagents Market Attractiveness, By Type
5 Global Sequencing Reagents Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Sequencing Reagents Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Oncology
5.3.2 Reproductive Health
5.3.3 Clinical Investigation
5.3.4 Agrigenomics & Forensics
5.3.5 Others
5.4 Application Comparison Matrix
5.5 Global Sequencing Reagents Market Attractiveness, by Application
6 Global Sequencing Reagents Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Sequencing Reagents Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Sequencing Reagents Market Attractiveness, by Region
8 North America Sequencing Reagents Market Analysis and Forecast
8.1 Key Findings
8.2 North America Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Sanger Sequencing
8.2.2 Next Generation Sequencing
8.2.3 Third Generation Sequencing
8.2.4 Other
8.3 North America Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Oncology
8.3.2 Reproductive Health
8.3.3 Clinical Investigation
8.3.4 Agrigenomics & Forensics
8.3.5 Others
8.4 North America Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Sequencing Reagents Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Sequencing Reagents Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Sanger Sequencing
9.2.2 Next Generation Sequencing
9.2.3 Third Generation Sequencing
9.2.4 Other
9.3 Europe Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Oncology
9.3.2 Reproductive Health
9.3.3 Clinical Investigation
9.3.4 Agrigenomics & Forensics
9.3.5 Others
9.4 Europe Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Sequencing Reagents Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Sequencing Reagents Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Sanger Sequencing
10.2.2 Next Generation Sequencing
10.2.3 Third Generation Sequencing
10.2.4 Other
10.3 Asia Pacific Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Oncology
10.3.2 Reproductive Health
10.3.3 Clinical Investigation
10.3.4 Agrigenomics & Forensics
10.3.5 Others
10.4 Asia Pacific Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Sequencing Reagents Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Sequencing Reagents Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Sanger Sequencing
11.2.2 Next Generation Sequencing
11.2.3 Third Generation Sequencing
11.2.4 Other
11.3 Latin America Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Oncology
11.3.2 Reproductive Health
11.3.3 Clinical Investigation
11.3.4 Agrigenomics & Forensics
11.3.5 Others
11.4 Latin America Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Sequencing Reagents Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Sequencing Reagents Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Sanger Sequencing
12.2.2 Next Generation Sequencing
12.2.3 Third Generation Sequencing
12.2.4 Other
12.3 Middle East & Africa (MEA) Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Oncology
12.3.2 Reproductive Health
12.3.3 Clinical Investigation
12.3.4 Agrigenomics & Forensics
12.3.5 Others
12.4 Middle East & Africa (MEA) Sequencing Reagents Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Sequencing Reagents Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Thermo Fisher Scientific
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Bioline
13.3.3 Takara Bio
13.3.4 ArcherDX
13.3.5 Fluidigm Corporation
13.3.6 Pacific Biosciences of California
13.3.7 F. Hoffmann-La Roche AG
13.3.8 Oxford Nanopore Technologies
13.3.9 Agilent Technologies
13.3.10 Illumina
13.3.11 BGI
13.3.12 Qiagen
14 Key Takeaways
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
